Latest article
Vitamin model OZiva raises $12 million in Collection B funding
Plant-based nutrition brand OZiva raised $ 12 million in a Series B funding round led by Eight Roads Ventures. The existing investor Matrix...
Comings & Goings: Most cancers fighters get health assist
Local fitness expert Jennifer Miramontes recently left FIT house focus on their business Cancer Champion Fitness.
Miramontes is a tough personal trainer who knows how...
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...